Meta-analysis: hidradenitis suppurativa a risk factor for depression and anxiety

  • Patel KR & al.
  • J Am Acad Dermatol
  • 17/12/2019

  • Brian Richardson, PhD
  • Clinical Essentials
L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano

Takeaway

  • Patients with hidradenitis suppurativa (HS) have higher odds of depression, anxiety, and suicidality, according to a systematic review and meta-analysis.

Why this matters

  • Studies examining the relationship between HS and depression/anxiety have shown conflicting results.

Key results

  • Patients with HS had increased prevalence and odds of:
    • Depression: 26.5% vs 6.6% (OR, 2.54; P<.001>
    • Anxiety: 18.1% vs 7.1% (OR, 2.00; P<.001>
  • The link to depression was significant (ORs; 95% CIs) in studies that:
    • Used self-report or physician diagnosis: 1.82 (1.51-2.19).
    • Used medical record review: 2.69 (2.23-3.24).
    • Were cross-sectional: 2.05 (1.79-2.36).
    • Included healthy control individuals: 2.62 (2.19-3.13).
  • The link to anxiety was significant in studies that:
    • Used self-report or physician diagnosis: 1.67 (1.37-2.05).
    • Used medical record review: 2.13 (1.70-2.66).
    • Included healthy control individuals: 2.03 (1.59-2.60).
    • Used other dermatologic disorders as control individuals: 2.05 (1.88-2.22).
  • HS was associated with higher use of antidepressants (OR, 1.85; 1.26-2.71) and suicide prevalence (data not shown).

Study design

  • 27 studies identified by systematic review were included in the meta-analysis.
  • Funding: None disclosed.

Limitations

  • Individual patient data not available.